Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study to Investigate the Impacts of Peripheral Blood Dendritic Cells-Derived Exosomes at Early Phase on the Prognosis in Human Sepsis

NCT02957279 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT02957279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02957279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study to Investigate the Impacts of Peripheral Blood Dendritic Cells-Derived Exosomes at Early Phase on the Prognosis in Human Sepsis
Lead sponsor
Jinling Hospital, China
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2016
Completion date
October 31, 2017
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis